Hyperlipidemia is diagnosed with a simple blood test called a lipid panel, which measures the levels of different fats in your blood. For adults, the key threshold is a total cholesterol of 200 mg/dL or higher, though the diagnosis also depends on your LDL cholesterol, HDL cholesterol, and triglyceride levels. The process is straightforward, but what happens after the numbers come back involves more nuance than most people expect.
What a Lipid Panel Measures
A standard lipid panel directly measures three things: total cholesterol, HDL cholesterol (the protective kind), and triglycerides. Your LDL cholesterol, the type most strongly linked to artery-clogging plaque, is then estimated using a mathematical formula based on those three values. Non-HDL cholesterol is also calculated by subtracting your HDL from your total cholesterol, and it captures a broader picture of harmful cholesterol particles than LDL alone.
Some providers also order a measurement of lipoprotein(a), a genetically determined particle that independently raises cardiovascular risk. Current guidelines recommend checking it at least once in every adult. A level of 125 nmol/L or higher is considered high and is associated with roughly a 40% increase in heart disease risk, while levels above 250 nmol/L double that risk or more.
The Numbers That Define Hyperlipidemia
For adults 20 and older, these are the healthy targets:
- Total cholesterol: Less than 200 mg/dL
- LDL cholesterol: Less than 100 mg/dL
- Non-HDL cholesterol: Less than 130 mg/dL
- HDL cholesterol: 60 mg/dL or higher is ideal. Below 40 mg/dL in men or below 50 mg/dL in women is considered low.
- Triglycerides: Less than 150 mg/dL
Triglyceride levels get their own severity scale. Mild elevation falls between 150 and 199 mg/dL, moderate between 200 and 499 mg/dL, and severe is anything above 500 mg/dL. That severe category carries a risk of pancreatitis, not just heart disease, so it typically gets treated more urgently.
For children and teens 19 and younger, the thresholds are slightly different: total cholesterol should be below 170 mg/dL, LDL below 110 mg/dL, non-HDL below 120 mg/dL, and HDL above 45 mg/dL.
Do You Need to Fast Before the Test?
For most people, no. Guidelines from cardiology societies across the U.S., Europe, Canada, and elsewhere now endorse non-fasting lipid panels as perfectly acceptable for routine screening. Eating before the test raises triglycerides by an average of only about 26 mg/dL, peaking three to four hours after your last meal. Total cholesterol, LDL, and non-HDL shift by roughly 8 mg/dL at most, and HDL barely changes at all.
That said, fasting still matters in specific situations. If you have a history of high triglycerides (particularly above 400 mg/dL), a family history of early heart disease, or suspected genetic cholesterol disorders, a fasting sample drawn after 8 to 12 hours without food gives a more precise baseline. People with higher baseline triglycerides also see larger swings after eating, which can make non-fasting results harder to interpret. Your provider will tell you whether fasting is necessary for your situation.
When and How Often to Get Screened
Several major medical organizations recommend universal screening for children at ages 9 to 11, with a second round between ages 17 and 21. Children with a family history of heart disease or known cholesterol problems can be screened as early as age 2. Young adults without known lipid issues can then be screened every five years starting at age 19, with more frequent checks as they get older or if other risk factors develop.
Once you’re on cholesterol-lowering treatment, the monitoring schedule changes. A follow-up lipid panel is typically drawn 4 to 12 weeks after starting or adjusting medication to see if the treatment is working. After that, once your levels are stable, annual testing is usually enough.
Ruling Out Underlying Causes
Not all high cholesterol is a standalone problem. In a study of over 800 patients referred to a lipid clinic, 28% had an underlying condition driving their abnormal numbers. The most common culprits were excessive alcohol intake (10% of cases) and uncontrolled diabetes (8%).
When lipid levels come back elevated, providers typically check for secondary causes before settling on a diagnosis of primary hyperlipidemia. The conditions that commonly push cholesterol or triglycerides higher include hypothyroidism (an underactive thyroid slows the body’s ability to clear cholesterol from the blood), type 2 diabetes (insulin resistance raises triglycerides and lowers HDL), kidney disease and nephrotic syndrome, cholestatic liver disease, and obesity. Treating the underlying condition often improves the lipid numbers on its own, which is why this step matters before committing to long-term cholesterol medication.
Beyond the Lipid Panel: ApoB Testing
A standard lipid panel estimates how much cholesterol is floating around in your blood, but it doesn’t tell you how many harmful particles are carrying it. That’s where apolipoprotein B (apoB) comes in. Every particle capable of depositing cholesterol in your artery walls carries exactly one apoB molecule, so an apoB level is essentially a particle count.
ApoB testing is especially useful when triglycerides are 200 mg/dL or higher, because elevated triglycerides make standard LDL calculations less accurate. It’s also recommended for diagnosing certain genetic lipid disorders and for evaluating residual risk in people already on treatment whose LDL looks fine on paper. European guidelines go further, recommending apoB as a preferred marker over standard cholesterol measures in people with diabetes, obesity, or very low LDL. An apoB level above 130 mg/dL is considered a risk-enhancing factor for heart disease, and targets for people already at high risk go as low as 55 mg/dL.
How Cardiovascular Risk Shapes the Diagnosis
Diagnosing hyperlipidemia isn’t just about the cholesterol numbers themselves. Two people with the same LDL of 140 mg/dL may be treated very differently depending on their overall cardiovascular risk profile. Providers use the ACC/AHA Pooled Cohort Equations (often called the ASCVD Risk Estimator) to calculate your 10-year probability of a heart attack or stroke.
The calculator requires your age, sex, race, total cholesterol, HDL cholesterol, systolic blood pressure, whether you take blood pressure medication, whether you have diabetes, and whether you smoke. The resulting percentage helps determine how aggressively elevated lipids need to be managed. Someone with a 10-year risk below 5% and mildly elevated LDL might focus on lifestyle changes alone, while the same LDL in someone with a 15% risk could prompt medication.
Diagnosing Genetic (Familial) Hypercholesterolemia
If your LDL is very high, especially above 190 mg/dL as an adult or above 160 mg/dL in someone under 20, providers consider familial hypercholesterolemia (FH), an inherited condition that causes dangerously elevated cholesterol from birth. FH affects roughly 1 in 250 people, but most cases go undiagnosed.
Several scoring systems exist to identify it. The Dutch Lipid Clinic Network criteria assign points based on family history, personal history of early heart disease, physical signs like thickened tendons (tendon xanthomas) or a white ring around the cornea (corneal arcus), LDL levels, and genetic testing results. A score above 8 makes the diagnosis definite, 6 to 8 is probable, and 3 to 5 is possible. The Simon Broome criteria take a simpler approach, combining very high cholesterol with either physical signs or a confirmed genetic mutation.
Genetic testing can identify mutations in specific genes responsible for clearing LDL from the bloodstream, though a clinical diagnosis based on cholesterol levels and family history is often enough to start treatment. What makes FH important to catch is that people who have it accumulate artery damage starting in childhood, so early identification, sometimes through cascade screening of family members, can prevent heart attacks decades down the road.